New real-world study reveals oral corticosteroid overuse in patients with chronic rhinosinusitis with nasal polyps Français
According to the ACTIONS study, 39% of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) faced overexposure to oral corticosteroids (OCS) before beginning biologic therapy.
ACTIONS was carried out by GSK in collaboration with Asthma Canada and leading Canadian Rhinologists.
MISSISSAUGA, ON, June 10, 2025 /CNW/ - A new Canadian real-world study, ACTIONS (chAracterizing oral Corticosteroid use in patients with chronic rhInOsinusitis with Nasal polypS in Canada), revealed patterns of oral corticosteroid (OCS) use among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) prior to starting biologic treatments. The full findings were recently presented at the Canadian Society of Otolaryngology Head and Neck Surgery Annual Meeting in Fredericton, New Brunswick.
The study findings revealed that 81% of CRSwNP patients were prescribed OCS at least once in the 24 months prior to starting a biologic treatment with 39% of patients being overexposed to OCS by the time they started a biologic. These findings highlight the need for heightened awareness and education to prevent OCS overexposure and enhance patient care.
CRSwNP is a chronic inflammatory disease of the paranasal sinuses and nasal mucosa leading to the growth of nasal polyps; 1 CRSwNP is associated with significant disease burden which negatively affects patients' quality of life. 2 Treatment for CRSwNP involves a combination of medical and surgical interventions. OCS are a common and effective medical treatment option for patients with CRSwNP, often used alongside nasal saline irrigation for short-term control of symptoms. 3 Despite their proven short-term efficacy, OCS are also associated with increased risk of short- and long-term adverse effects, with guidelines in respiratory disease recommending limiting use when possible. 4,5
Biologics have emerged as a newer treatment option with demonstrated effectiveness in managing CRSwNP, including decreasing the dependence on OCS. 6-8 The ACTIONS study revealed critical patterns of OCS use among CRSwNP patients, underscoring a significant unmet need that healthcare professionals should address.
ACTIONS was conducted by GSK and Asthma Canada in collaboration with Dr. Yvonne Chan from the University of Toronto, Dr. Marie-Noëlle Corriveau from Université Laval, and Dr. Andrew Thamboo from the University of British Columbia, with research support, input, and analytics provided by IQVIA Solutions Canada Inc.
"Our findings indicate that a significant proportion of severe CRSwNP patients are at risk of OCS overexposure. By considering earlier biologic initiation, when indicated, we can potentially reduce this risk and improve patient outcomes. Furthermore, collaboration among healthcare providers to promote awareness and adherence to these protocols will be vital in transforming patient care," said Dr. Marie-Noëlle Corriveau.
"The data clearly indicate that a proactive strategy involving earlier biologic therapy can play a pivotal role in managing CRSwNP more efficiently. Embracing these new approaches is not just beneficial, but essential for improving the quality of life for our patients," said Dr. Yvonne Chan.
"CRSwNP and asthma often coexist, share underlying mechanisms and influence each other's severity and management. This study is a critical step forward in understanding the treatment landscape for CRSwNP. It shows how vital it is to reduce our dependence on OCS and to find more sustainable and effective treatments. Ultimately, this could mean better health and quality of life for patients," said Jeffrey Beach, President & CEO, Asthma Canada.
"As a leader in respiratory health, GSK remains committed to be at the forefront of the fight against respiratory disease. The ACTIONS study further underscores this dedication by providing valuable insights, fostering scientific and research excellence, and driving innovation," added Dr. Michelle Horn, Country Medical Director, GSK Canada.
About CRSwNP
CRSwNP is caused by inflammation of the nasal lining that can lead to soft tissue growths, known as nasal polyps. 3,6 People with CRSwNP experience symptoms such as nasal obstruction, loss of smell, facial pain, sleep disturbance, infections and nasal discharge that can significantly affect their emotional and physical well-being. 1,6,10-11 IL-5 is a key cytokine (protein) in type 2 inflammation characterized by eosinophils (a type of white blood cell), which is present in up to 85% of people with CRSwNP. 1,6,10,11 IL-5 and eosinophils are frequently found in high concentrations in sinus and nasal polyp tissue of patients with CRSwNP and are associated with more severe disease. 13-19
About OCS
Oral corticosteroids (OCS) are systemic anti-inflammatory medications used to manage inflammatory conditions, including respiratory diseases, and allergic reactions. Unlike inhaled corticosteroids (ICS), which target the lungs directly, and intranasal corticosteroids (INCS) which target the nasal airways, OCS are ingested and distributed throughout the body. Common types include prednisone, methylprednisolone, and hydrocortisone. The use of OCS, including in repeated short bursts, can lead to significant health risks. The wide range of adverse effects associated with OCS include increased risk of infection and cardiovascular events, osteoporosis, type 2 diabetes mellitus, weight gain, and mood and behaviour disturbances. 20 In the ACTIONS study, overexposure to OCS is defined as total yearly dose of OCS ≥1,000 mg given that the risk of adverse effects significantly increases once a patient receives a cumulative lifetime exposure of 1000mg of OCS. 20
About GSK in respiratory
GSK continues to build on decades of pioneering work to deliver more ambitious treatment goals, develop the next generation standard of care, and redefine the future of respiratory medicine for hundreds of millions of people with respiratory diseases. With an industry-leading respiratory portfolio and pipeline of vaccines, targeted biologics and inhaled medicines, we are focused on improving outcomes and the lives of people living with all types of asthma and COPD along with less understood refractory chronic cough or rarer conditions like systemic sclerosis with interstitial lung disease. GSK is harnessing the latest science and technology with the aim of modifying the underlying disease dysfunction and preventing progression.
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.ca.
References
SOURCE GlaxoSmithKline Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
5 hours ago
- Cision Canada
Media Advisory - Simultaneous launch of Canadian space technologies Français
LONGUEUIL, QC, June 21, 2025 /CNW/ - Several technologies funded by the Canadian Space Agency under the Space Technology Development Program will be launched into space by SpaceX. These projects are a testament to Canada's leadership in space innovation. EarthDaily Analytics will use high-precision thermal imagers to monitor plant transpiration. The data collected could help farmers make decisions about irrigation, fertilization and crop rotation. It could also provide precise information about areas at greatest risk of wildfires, in order to protect our communities. INO provided infrared cameras as part of this project. Galaxia will launch its first satellite, MÖBIUS-1, a software-defined satellite designed to carry various types of Earth observation sensors. The MÖBIUS constellation could be used for a variety of applications, such as defence, environmental monitoring, agriculture, infrastructure, maritime operations and transportation. GHGSat will add two satellites to its commercial constellation, bringing the company's total to 13 methane detection satellites and one CO 2 detection satellite. Mission Control will test its onboard artificial intelligence (AI) software and machine learning operations system SpacefarerAI™ in partnership with Spire Global. Their Persistence mission aims to show how AI can analyze satellite images directly in space, thereby eliminating the need to send all data to Earth for processing. Xona Space Systems will test Pulsar, a demonstration satellite designed to validate a new generation of satellite navigation from low Earth orbit. This technology could improve precision and reliability of positioning services, including in urban areas, remote areas and the Arctic. Also contributing to the GHGSat and EarthDaily Analytics satellites are ABB 's business unit in Quebec, supplying sophisticated optical sensors, and Xiphos Systems, providing high-performance onboard processors. These innovations demonstrate the ability of Canadian companies to develop innovative technologies that meet the needs of the space program and have strong commercial potential. Media who wish to speak with a Canadian Space Agency expert or a representative from one of these Canadian companies are asked to contact the Media Relations Office.
Winnipeg Free Press
6 hours ago
- Winnipeg Free Press
B.C. student created wildfire map during own evacuation from Manitoba fire zone
University of British Columbia Okanagan geography student Jenna Taylor went home last month to spend time with her family in Flin Flon, Man. A relaxing break did not ensue. Taylor and her family would join thousands of evacuees on May 27, fleeing wildfires that prompted a provincewide state of emergency and spread to less than one kilometre from their home. Instead of despairing, Taylor put her skills to use by building an interactive website to provide visualizations of the spread of the fires, their intensity and other information. 'I mean, it's so easy in a situation like this to just kind of constantly be doom-scrolling through social media,' said Taylor, 'and it's hard to be in the dark and not know what's going on.' By manually pulling data from Canadian government sites and NASA databases, Taylor was able to create a resource for others affected by the wildfires. The site includes time-lapse visualizations of the fires, as well as wind and air-quality forecasts. 'In a way, it's hard because I wish I didn't have to make this project,' Taylor said. 'The reality of it is that I'm in this situation, and I guess I did the best work I could for the position that we're all in.' To date, the Manitoba wildfires have displaced more than 17,000 people, including 5,000 residents of Flin Flon near the Saskatchewan boundary. Among the hardest-hit locations was the village of Denare Beach, Sask., about 22 kilometres southwest of Flin Flon, where more than 200 primary residences burned down. 'It's a place that we all hold really close to our hearts, and that's really difficult,' said Taylor. UBC Okanagan said the site was a 'full emergency information hub.' It also lists ways for people to donate to evacuees and others suffering losses. 'I think that was my biggest thing was I wanted to spread awareness, not so much have this be simply like a fire update resource, because there's already lots of official government ones,' said Taylor. She credited a cartography and map-making course for the skills to build the site, which took her about two weeks. 'It was really nice to have that feeling and also know that I did something with my schooling that was more than just an assignment,' said Taylor. Jonathan Cinnamon, an associate professor with the university's Irving K. Barber Faculty of Arts and Social Sciences, said Taylor's website showed the real-world applications of such studies. 'A perfect example is Taylor's invaluable website, which contains up-to-date wildfire and weather maps to support decision-making in affected communities,' said Cinnamon. Weekly A weekly look at what's happening in Winnipeg's arts and entertainment scene. Residents of Flin Flon have been told they may be able to return by the middle of next week as officials prepare to lift the mandatory evacuation order. 'We're all ready to go home,' said Taylor, 'Hopefully, I can go back home to Flin Flon soon, and then in September, I'll be back in school, and I'm excited to be able to finish my degree soon.' She said her career goal was supporting people when devastating events occur. 'I think that'd be really cool one day.' This report by The Canadian Press was first published June. 18, 2025.
Cision Canada
7 hours ago
- Cision Canada
STATEMENT - CMA reflects on National Indigenous Peoples Day Français
OTTAWA, ON, June 21, 2025 /CNW/ - On this National Indigenous Peoples Day, the Canadian Medical Association (CMA) reflects on the rich history, strength and resilience of First Nations, Inuit and Métis Peoples. This year marks the 10 th anniversary of the Truth and Reconciliation Commission of Canada's report, which exposed the devastating legacy of Canada's residential schools, and the sixth anniversary of the report from the National Inquiry into Missing and Murdered Indigenous Women and Girls. We acknowledge and honour the stories that survivors have shared to help guide us toward a better future. With great humility, we continue our own reconciliation journey led by an Indigenous Guiding Circle composed of health leaders, Elders and Knowledge Keepers. This journey includes working in partnership to combat anti-Indigenous racism in health care and to support the medical profession in making the system safer for First Nations, Inuit and Métis patients and providers. In updating our Code of Ethics and Professionalism, our goal is to better reflect physicians' shared values in supporting patients and providers from Indigenous communities. Alongside Indigenous partners, we're leveraging our voice to also call on the federal government to reintroduce important First Nations clean water legislation and support First Nations, Inuit and Métis-led health care. Our commitment extends to amplifying Indigenous voices and highlighting critical issues through the Indigenous Health Journalism Fellowship. On National Indigenous Peoples Day, we recognize the importance of acknowledging the truth, rebuilding trust and taking the steps necessary to fulfill our promise of transforming the health system to provide culturally safe, trauma-informed care for Indigenous Peoples. Dr. Margot Burnell President, CMA SOURCE Canadian Medical Association
